RIGEL PHARMACEUTICALS INC (RIGL) › Shareholders' EquityRIGEL PHARMACEUTICALS INC (RIGL) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2008: $104.17M2009: $109.87M2010: $166.13M2011: $236.15M2012: $289.10M2013: $208.25M2014: $128.25M2015: $91.38M2016: $55.03M2017: $100.65M2018: $109.88M2019: $53.81M2020: $34.03M2021: $30.37M2022: -$13.62M2023: -$28.64M2024: $3.29M2025: $391.48M$391.48M2008Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025$391.48M+11806.3%2024$3.29M+111.5%2023-$28.64M-110.4%2022-$13.62M-144.8%2021$30.37M-10.7%2020$34.03M-36.8%2019$53.81M-51.0%2018$109.88M+9.2%2017$100.65M+82.9%2016$55.03M-39.8%2015$91.38M-28.7%2014$128.25M-38.4%2013$208.25M-28.0%2012$289.10M+22.4%2011$236.15M+42.1%2010$166.13M+51.2%2009$109.87M+5.5%2008$104.17M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share